Kyowa Medex Co., Ltd.

1-8-10, Harumi
Tokyo,  104-6004

  • Booth: 525


We are excited to announce the launch of MedFrontier FGF23 kit. Intact FGF23 is being studied as a significant marker in Osteomalacia and Kidney failure. The MedFrontier FGF23 has excellent performance that two murine monoclonal antibodies enable you to detect active form of FGF23, and the chemiluminescence-based microplate kit brings about wide measurement range of intact FGF23. The MedFrontier FGF23 is designed for Research Use, not FDA cleared. We welcome you to visit our booth if you learn more.

 Additional Info

Business Needs:
Distributor/Agent/Representative, Licensing Agreements
Countries of Interest:
United States